Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

31results about How to "Solve the problem of ischemia and hypoxia" patented technology

Composition for treating inflammatory bowel disease

InactiveCN105412238AEnhance blood supplyEnhanced oxygen supplyHydroxy compound active ingredientsDigestive systemEnteropathyMucous layer
The invention discloses a composition for treating inflammatory bowel disease, and belongs to the field of drugs. The composition comprises ganoderma, radix salviae miltiorrhizae, poria cocos, threonine, serine, cysteine, vitamin C, vitamin E, vitamin A and beta-carotene, wherein ganoderma, radix salviae miltiorrhizae and poria cocos have efficacies of strengthening blood supply and oxygen supply to the human body; threonine, serine and cysteine are components of mucoprotein; vitamin C, vitamin E, vitamin A and beta-carotene have functions of inhibiting the activity of oxygen free radicals, scavenging the oxygen free radicals, and protecting human cells. The composition provides nutrition, oxygen and raw materials for generation, renewal and repairing of goblet cells as well as forming of an intestinal surface mucous layer barrier by utilizing mucoprotein secreted by the goblet cells, has obvious effects of eliminating inflammation, repairing intestinal tissues and building the normal intestinal surface mucous layer barrier for the human body, and is used for effectively treating the inflammatory bowel disease.
Owner:何松庆

Composition for treating inflammatory bowel diseases

The invention discloses a composition for treating inflammatory bowel diseases, belonging to the field of medicines. The composition is prepared from the following components: lucid ganoderma, radix salviae miltiorrhizae, poria cocos, glutamine, threonine, serine, cysteine, vitamins C, E and A, and beta-carotene. Lucid ganoderma, radix salviae miltiorrhizae and poria cocos have the efficacy of boosting the blood supply and the oxygen supply for the human body; glutamine is the major energy source of the intestinal mucosa; threonine, serine and cysteine are the constituent parts of mucoprotein; vitamins C, E and A, and beta-carotene have the effects of suppressing the activity of oxygen free radicals, eliminating the oxygen free radicals, and protecting the human cells. The composition provides nutrition, oxygen and raw materials for the generation, renewing and repair of goblet cells, and the process that the goblet cells secrete mucoprotein to form a slime layer barrier for the surface of the intestinal tract. The composition has obvious effects in terminating the inflammation, repairing the intestinal tissue, and establishing the normal slime layer barrier for the surface of the human intestinal tract, and belongs to an effective composition for treating the inflammatory bowel diseases.
Owner:何松庆

Composition for treating inflammatory bowel disease

InactiveCN105434522AEnhance blood supplyEnhanced oxygen supplyHydroxy compound active ingredientsDigestive systemEnteropathySalvia miltiorrhiza
The invention discloses a composition for treating the inflammatory bowel disease, and belongs to the field of medicines. The composition comprises Mythic Fungus, Salvia miltiorrhiza, ginseng, Poria cocos, glutamine, threonine, serine, cysteine, vitamin C, vitamin E, vitamin A and beta-carotene. Mythic Fungus, Salvia miltiorrhiza, ginseng and Poria cocos have the efficacy of enhancing human body blood supply and oxygen supply; glutamine is the main energy source of intestinal mucosa; threonine, serine and cysteine are composition parts of mucoproteins; and vitamin C, vitamin E, vitamin A and beta-carotene have oxyradical activation repression, oxyradical removal and human body cell protection effects. The composition provides nutrition, oxygen and raw materials for generation, updating and restoration of goblet cells and an intestinal tract surface mucus layer barrier composed of mucoproteins secreted by the goblet cells. The composition has obvious inflammation termination, intestinal tract tissue restoration and human body normal intestinal tract surface mucus layer barrier construction effects, and is an effective composition for treating the inflammatory bowel disease.
Owner:何松庆
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products